Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-11-25 Garg Pushkal CMO & EVP Dev & Med Affairs Grant or award +3,434 19,139
2024-11-25 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +3,434 32,326
2024-11-25 Tanguler Tolga EVP, Chief Commercial Officer Grant or award +3,000 14,660
2024-10-17 Reitan Colleen F Director Purchase +4 $302.67 $1K 36
2024-08-29 Reitan Colleen F Director Purchase +32 $286.00 $9K 32
2017-05-31 Sanofi 10% owner Purchase +297,501 $71.87 $21.4M 10,554,134
2016-02-01 Sanofi 10% owner Purchase +205,030 $69.75 $14.3M 10,256,633
2015-01-29 Sanofi 10% owner Purchase +97,118 $95.00 $9.2M 10,051,603
2015-01-26 Sanofi 10% owner Purchase +647,448 $95.00 $61.5M 9,954,485
2015-01-22 Sanofi 10% owner Purchase +196,251 $93.17 $18.3M 9,307,037
2015-01-22 Sanofi 10% owner Purchase +196,251 $9,317.00 $1.8B 9,307,037
2014-03-25 Sanofi 10% owner Purchase +344,448 $66.88 $23.0M 9,110,786
2012-09-20 NOVARTIS AG 10% owner Sale −1,551,896 $19.42 $30.1M 4,051,002
2010-04-23 NOVARTIS AG 10% owner Purchase +55,223 $17.99 $993K 5,602,898
2009-05-06 NOVARTIS AG 10% owner Purchase +65,922 $17.50 $1.2M 5,547,675
2008-05-08 NOVARTIS AG 10% owner Purchase +213,888 $25.29 $5.4M 5,481,753

Page 41 of 41 · 816 trades